From Ben Troyer at Med Central Health System: Should lupus anticoagulant testing be offered on a STAT basis? Our LA test volume is pretty low—we average 3–5 requests per week. We make the test available as a STAT, but I’m not sure that this is necessary or appropriate. I’d appreciate any input. Thanks!
From Kelly Townsend: Is anyone using the BioData PAP-8e for ristocetin cofactor (RICO) testing? We’ve moved from the old PAP-4 to the newer version, but are struggling with the assay. We’d appreciate being able to correspond with anyone who is sucessfully running RICO on the PAP-8e.
You are invited to the Clinical and Laboratory Update in Thrombosis, Anticoagulation and Vascular Medicine: A Board Review Primer, this fall’s Mayo School of Continuous Professional Development at the Mayo Civic Center, Rochester, Minnesota. This is a new location for the meeting, and you will find both The Fritsma Factor and Precision BioLogic represented in the exhibit. This is one of the iconic hemostasis meetings of the year, and we hope to see you there.
In follow-up to Cassandra McGeachy’s August 7 question on the euglobulin lysis time (ELT), I’ve found two references for upgraded ELT methods that may be helpful.They are:
- Cellai AP. Lami D, Magi A, et al. Assessment of fibrinolytic activity by measuring the lysis time of a tissue factor-induced clot: a feasibility evaluation. Clin Appl Thromb Hemost 2010;16:337–44.
- Smith AA, Jacobson LJ, Miller BI, et al. A new euglobulin clot lysis assay for global fibrinolysis. Thrombos Research 2003:112:329–37.
George presents “Monitoring the New Anticoagulants, Whatever Happened to the PT and PTT?” and “Managing Trauma-induced Coagulopathy,” for the 2014 ASCLS-HI Clinical Laboratory Symposium Update at the Ko’olan Conference Center near Honolulu, Hawaii, October 21 and 22 (well, someone has to do it!). Times for George’s talks are to be announced. We hope you can attend. Go to ASCLS-HI and click on 2014 ASCLS-HI Clinical Laboratory Symposium Update.